Abatacept concentrations in maternal serum and breast milk during breastfeeding and an infant safety assessment: a case study

Rheumatology (Oxford). 2019 Sep 1;58(9):1692-1694. doi: 10.1093/rheumatology/kez135.

Authors

Jumpei Saito¹, Naho Yakuwa², Chinatsu Takai², Kayoko Kaneko³, Mikako Goto³, Ken Nakajima², Akimasa Yamatani¹, Atsuko Murashima^{2

3}

Affiliations

¹ Department of Pharmaceuticals, National Center for Child Health and Development.
² Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development.
³ Division of Maternal Medicine, Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.

PMID: 31323087
DOI: 10.1093/rheumatology/kez135

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Abatacept / pharmacokinetics*
Adult
Antirheumatic Agents / pharmacokinetics*
Arthritis, Rheumatoid / drug therapy
Breast Feeding*
Female
Humans
Infant, Newborn
Milk, Human / metabolism*
Pregnancy
Pregnancy Complications / drug therapy

Substances

Antirheumatic Agents
Abatacept